Beijing Hotgen Biotech Co (SHSE:688068) Other Income (Expense) : ¥-24.6 Mil (TTM As of Mar. 2024)

View and export this data going back to 2019. Start your Free Trial

What is Beijing Hotgen Biotech Co Other Income (Expense)?

Beijing Hotgen Biotech Co's other income expense for the Beijing Hotgen Biotech Co's pretax income for the three months ended in Mar. 2024 was ¥11.1 Mil. Its other income expense for the trailing twelve months (TTM) ended in Mar. 2024 was ¥-24.6 Mil.

Beijing Hotgen Biotech Co Other Income (Expense) Historical Data

The historical data trend for Beijing Hotgen Biotech Co's Other Income (Expense) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Beijing Hotgen Biotech Co Other Income (Expense) Chart

Beijing Hotgen Biotech Co Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Other Income (Expense)

Get a 7-Day Free Trial

1.74

7.91

-101.21

-192.49

-21.87

Beijing Hotgen Biotech Co Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Other Income (Expense)	Get a 7-Day Free Trial															13.79	-15.14	-9.06	-11.46	11.09

Beijing Hotgen Biotech Co Other Income (Expense) Calculation

Other income expense includes minority interest. Minority interest is a significant but non-controlling ownership of less than 50% of a company's voting shares by either an investor or another company.

Other Income (Expense) for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥-24.6 Mil.

Beijing Hotgen Biotech Co (SHSE:688068) Other Income (Expense) Explanation

Minority interest is reported on the consolidated income statement as a share of profit belonging to minority shareholders.

Beijing Hotgen Biotech Co (SHSE:688068) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Beijing Hotgen Biotech Co Ltd (SHSE:688068) » Definitions » Other Income (Expense)

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 9 Tianfu Street, 9th Building, Bio-Medical Base, Daxing District, Beijing, CHN, 102600

Website

http://www.hotgen.com.cn

Beijing Hotgen Biotech Co Ltd is engaged in the development and manufacturing of innovative in-vitro diagnostic, point-of-care-testing and biodefense products.

Executives

Zhou Xin

Director

Beijing Hotgen Biotech Co (SHSE:688068) Headlines

No Headlines